We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Study Suggests Fractures Not Improved by Post-Surgery Ultrasound Treatment

By HospiMedica International staff writers
Posted on 04 Nov 2016
The results of a new clinical trial indicate that treatment using Low-Intensity Pulsed Ultrasound (LIPUS), following surgery to repair a bone fracture may not improve the chances of recovery, despite popular belief that it does.

The US Food and Drug Administration (FDA) approved the use of LIPUS for the healing of fractures in 1994. More...
LIPUS is often used for tibia fractures that heal slowly and that often require follow-up surgery.

The results of the randomized controlled trial that included 501 patients from academic trauma centers in North America were published in the October 25, 2016, issue of the British Medical Journal (BMJ). The patients had undergone surgical repair for a lower leg (tibia) fracture between the years 2008 and 2012.

The researchers from the McMaster University (Hamilton, ON, Canada) concluded that there was no difference in the recovery time between those patients that received LIPUS treatment and those that received a placebo treatment. There was also no difference in the time it took for functional recovery including quality of life, leisure activities, return to work, or the time to full weight-bearing activities between the two patient groups.

Xavier Griffin, associate professor, trauma surgery, the University of Oxford, said, "These authors report important patient-centered outcomes...showing that low intensity pulsed ultrasound is of no benefit to adults with tibia fractures. It is time for us to make good use of their determination and abandon this ineffective treatment."

Related Links:
McMaster University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.